Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of NeurodegenerationAnna Dittrich, Silke Kern, Michael Schöll et al.|Neurology|2023Cited by 74
Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community‐based sample of 70‐year‐oldsAnna Dittrich, Silke Kern, Nicholas J. Ashton et al.|Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring|2022Cited by 36
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathologyHanna Huber, Nicholas J. Ashton, Laia Montoliu-Gaya et al.|Nature Medicine|2026Cited by 11
Plasma and cerebrospinal fluid neurofilament light protein concentrations are differentially associated with biomarker evidence of neurodegeneration in a community‐based population of 70‐year‐oldsAnna Dittrich, Silke Kern, Nicholas J. Ashton et al.|Alzheimer s & Dementia|2021Cited by 0
Biomarker evidence of neurodegeneration in chronic kidney disease, in a general populationAnna Dittrich, Silke Kern, Eric Westman et al.|Alzheimer s & Dementia|2023Cited by 0